肿瘤药学
腫瘤藥學
종류약학
ANTI-TUMOR PHARMACY
2013年
5期
353-356
,共4页
高危型人乳头瘤病毒%病毒负荷量%宫颈癌%癌前病变
高危型人乳頭瘤病毒%病毒負荷量%宮頸癌%癌前病變
고위형인유두류병독%병독부하량%궁경암%암전병변
Type high-risk human papilloma virus%Virus load%Cervical cancer%Precancerous lesions
目的:探讨高危型人乳头瘤病毒的病毒负荷量与宫颈癌及其癌前病变的关系。方法选择我院妇科门诊进行宫颈病变检查的患者2290例,检测所有患者高危型HPV-DNA的载量并对其宫颈组织进行病理活检。结果2290例宫颈病变患者中,病理诊断为慢性宫颈炎占93.58%;Ⅰ期癌前病变占1.83%;Ⅱ期癌前病变占1.62%;Ⅲ期癌前病变占1.79%;宫颈癌占1.18%;537例患者高危型HPV-DNA检测结果为阳性;其余为阴性。慢性宫颈炎、Ⅰ、Ⅱ、Ⅲ期癌前病变、宫颈癌的高危型HPV病毒负荷量的四分位数间距分别为:0.35~0.15 pg·mL-1、38.52~0.20 pg·mL-1、516.89~3.88 pg·mL-1、420.82~16.66 pg·mL-1、1243.81~14.53 pg·mL-1。与宫颈炎患者比较,Ⅰ、Ⅱ、Ⅲ期癌前病变、宫颈癌患者的病毒负荷量显著升高(P<0.05)。Ⅰ期癌前病变患者的病毒负荷量显著低于Ⅱ、Ⅲ期癌前病变和宫颈癌患者(P<0.05)。结论高危型人乳头瘤病毒的病毒负荷量与宫颈癌及其癌前病变有密切的关系。
目的:探討高危型人乳頭瘤病毒的病毒負荷量與宮頸癌及其癌前病變的關繫。方法選擇我院婦科門診進行宮頸病變檢查的患者2290例,檢測所有患者高危型HPV-DNA的載量併對其宮頸組織進行病理活檢。結果2290例宮頸病變患者中,病理診斷為慢性宮頸炎佔93.58%;Ⅰ期癌前病變佔1.83%;Ⅱ期癌前病變佔1.62%;Ⅲ期癌前病變佔1.79%;宮頸癌佔1.18%;537例患者高危型HPV-DNA檢測結果為暘性;其餘為陰性。慢性宮頸炎、Ⅰ、Ⅱ、Ⅲ期癌前病變、宮頸癌的高危型HPV病毒負荷量的四分位數間距分彆為:0.35~0.15 pg·mL-1、38.52~0.20 pg·mL-1、516.89~3.88 pg·mL-1、420.82~16.66 pg·mL-1、1243.81~14.53 pg·mL-1。與宮頸炎患者比較,Ⅰ、Ⅱ、Ⅲ期癌前病變、宮頸癌患者的病毒負荷量顯著升高(P<0.05)。Ⅰ期癌前病變患者的病毒負荷量顯著低于Ⅱ、Ⅲ期癌前病變和宮頸癌患者(P<0.05)。結論高危型人乳頭瘤病毒的病毒負荷量與宮頸癌及其癌前病變有密切的關繫。
목적:탐토고위형인유두류병독적병독부하량여궁경암급기암전병변적관계。방법선택아원부과문진진행궁경병변검사적환자2290례,검측소유환자고위형HPV-DNA적재량병대기궁경조직진행병리활검。결과2290례궁경병변환자중,병리진단위만성궁경염점93.58%;Ⅰ기암전병변점1.83%;Ⅱ기암전병변점1.62%;Ⅲ기암전병변점1.79%;궁경암점1.18%;537례환자고위형HPV-DNA검측결과위양성;기여위음성。만성궁경염、Ⅰ、Ⅱ、Ⅲ기암전병변、궁경암적고위형HPV병독부하량적사분위수간거분별위:0.35~0.15 pg·mL-1、38.52~0.20 pg·mL-1、516.89~3.88 pg·mL-1、420.82~16.66 pg·mL-1、1243.81~14.53 pg·mL-1。여궁경염환자비교,Ⅰ、Ⅱ、Ⅲ기암전병변、궁경암환자적병독부하량현저승고(P<0.05)。Ⅰ기암전병변환자적병독부하량현저저우Ⅱ、Ⅲ기암전병변화궁경암환자(P<0.05)。결론고위형인유두류병독적병독부하량여궁경암급기암전병변유밀절적관계。
Objective To investigate the viral load of high-risk human papilloma virus and its relationship with cervical cancer and precancerous lesions. Methods Select 2290 cases of patients with cervical lesions from the hospital outpatient service of gy-naecology department, and detect the viral load of high-risk HPV-DNA of all patients and the cervical tissue pathological biopsy. Results In 2290 patients with cervical lesions, the pathological diagnosis of chronic cervicitis accounted for 93.58%;stageⅠprecancerous lesions accounted for 1.83%;stageⅡprecancerous lesions accounted for 1.62%;stageⅢprecancerous lesions ac-counted for 1.79%;Cervical cancer accounted for 1.18%. 537 cases of patients had positive results of high-risk type HPV-DNA test and the rest were negative. The interquartile range of high-risk type HPV virus load were 0.35~0.15 pg·mL-1, 38.52~0.20 pg·mL-1, 516.89~3.88 pg·mL-1, 420.82~16.66 pg·mL-1, 1243.81~14.53 pg·mL-1 respectively for chronic cervicitis,Ⅰ,Ⅱ,Ⅲprecancerous lesions, cervical cancer. Compared with patients with cervicitis, patients withⅠ,Ⅱ,Ⅲperiod precancerous le-sions, cervical cancer had significantly increased viral load (P<0.05). Patients withⅠperiod precancerous lesions also had signifi-cantly lower viral load than those withⅡprecancerous lesions,Ⅲprecancerous lesions and cervical cancer (P<0.05). Conclusion High-risk human papilloma virus viral load has a close relationship with cervical cancer and precancerous lesions.